Bio-Techne Target Price

Where could TECH trade next? Consensus target price: $73.

Get informed when a big investor buys or sells

+ Follow

Share Price

$72.58

Average Target Price

$73.00

0.6% upside

5 analysts in the last 4 months

High: $73 | Low: $73

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-13	Wells Fargo	$73	0.6% upside
2026-06-26	StephensSteven Etoch	$73	0.6% upside
2026-06-26	Robert W. BairdCatherine Ramsey Schulte	$73	0.6% upside
2026-06-26	Deutsche BankJustin Bowers	$73	0.6% upside
2026-06-25	Leerink PartnersMarket Perform	$73	0.6% upside
2026-06-11	Piper Sandler	$65	10.4% downside
2026-05-14	RBC Capital	$62	14.6% downside
2026-05-07	Evercore ISIDaniel Markowitz	$50	31.1% downside
2026-05-07	Stifel Nicolaus	$50	31.1% downside
2026-05-07	Robert W. Baird	$49	32.5% downside
2026-02-05	Stifel Nicolaus	$65	10.4% downside
2026-02-05	UBS	$79	8.8% upside
2026-02-05	Robert W. Baird	$70	3.6% downside
2026-01-05	Evercore ISI	$62	14.6% downside
2025-12-12	Deutsche BankJustin Bowers	$72	0.8% downside
2025-11-20	Argus Research	$68	6.3% downside
2025-11-06	Evercore ISI	$68	6.3% downside
2025-09-02	RBC CapitalConor McNamara	$73	0.6% upside
2025-03-17	Evercore ISI	$75	3.3% upside
2024-10-31	Robert W. BairdCatherine Schulte	$84	15.7% upside
2024-10-30	KeyBancPaul Knight	$80	10.2% upside
2024-08-16	ScotiabankSung Ji Nam	$83	14.4% upside
2022-12-14	Deutsche Bank	$100	37.8% upside
2022-12-12	Citigroup	$100	37.8% upside
2022-12-07	RBC Capital	$89	22.6% upside
2022-12-05	Stephens	$105	44.7% upside
2022-05-05	KeyBancPaul Knight	$125	72.2% upside
2022-04-25	Wells Fargo	$92.5	27.4% upside
2021-05-06	CitigroupPatrick B Donnelly	$106.25	46.4% upside

Bio-Techne (TECH) FAQ

Bio-Techne's target price stands at $73. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $73 for TECH implies 0.6% upside versus today's price ($72.58). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Bio-Techne's target price evolved across reporting periods, while the comparison chart places TECH next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Bio-Techne's reading of $73 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.